Mangalam Total Liab vs Non Currrent Assets Other Analysis

MANGALAM

103.56 2.54 2.51%

Mangalam Drugs financial indicator trend analysis is infinitely more than just investigating Mangalam Drugs And recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mangalam Drugs And is a good investment. Please check the relationship between Mangalam Drugs Total Liab and its Non Currrent Assets Other accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangalam Drugs And. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Liab vs Non Currrent Assets Other

Total Liab vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mangalam Drugs And Total Liab account and Non Currrent Assets Other. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Mangalam Drugs' Total Liab and Non Currrent Assets Other is -0.32. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Mangalam Drugs And, assuming nothing else is changed. The correlation between historical values of Mangalam Drugs' Total Liab and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Mangalam Drugs And are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Total Liab i.e., Mangalam Drugs' Total Liab and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

-0.32

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Most indicators from Mangalam Drugs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mangalam Drugs And current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangalam Drugs And. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 471.8 M, whereas Tax Provision is projected to grow to (21.9 M).

	2022	2023	2024	2025 (projected)
Gross Profit	1.2B	188.1M	216.3M	205.5M
Total Revenue	3.7B	3.7B	4.2B	2.6B

Gross Profit Total Revenue

Mangalam Drugs fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Short Term Debt	Short Term Investments	Other Liab	Net Tangible Assets
Total Assets		0.47	-0.36	0.84	0.95	0.97	0.78	0.89	0.66	0.98	-0.25	0.5	0.43	0.8	0.09	0.83	0.1	0.07	0.95	0.98	0.85	0.88	0.86	0.1	0.93	0.95
Short Long Term Debt Total	0.47		-0.4	0.3	0.62	0.56	-0.04	0.56	0.43	0.48	0.39	0.31	0.73	0.57	-0.27	0.25	0.03	0.46	0.27	0.44	0.53	0.32	0.14	0.43	0.65	0.61
Other Current Liab	-0.36	-0.4		-0.36	-0.27	-0.42	-0.41	-0.29	-0.22	-0.38	-0.53	-0.16	-0.24	-0.15	-0.18	-0.31	0.33	0.03	-0.41	-0.34	-0.23	-0.3	-0.21	-0.32	-0.3	-0.29
Total Current Liabilities	0.84	0.3	-0.36		0.75	0.79	0.72	0.88	0.53	0.81	-0.46	0.42	0.32	0.74	0.0	0.96	0.12	0.06	0.85	0.84	0.78	0.81	0.78	0.05	0.79	0.81
Total Stockholder Equity	0.95	0.62	-0.27	0.75		0.98	0.6	0.93	0.68	0.97	-0.15	0.47	0.51	0.86	-0.09	0.75	0.08	0.21	0.81	0.9	0.89	0.77	0.8	0.17	0.97	0.99
Property Plant And Equipment Net	0.97	0.56	-0.42	0.79	0.98		0.71	0.91	0.63	0.99	-0.12	0.43	0.47	0.85	-0.04	0.77	0.07	0.18	0.87	0.91	0.91	0.78	0.85	0.18	0.96	0.98
Net Debt	0.78	-0.04	-0.41	0.72	0.6	0.71		0.58	0.24	0.76	-0.31	0.15	0.08	0.53	0.37	0.71	0.1	-0.26	0.88	0.76	0.58	0.64	0.84	-0.24	0.6	0.64
Retained Earnings	0.89	0.56	-0.29	0.88	0.93	0.91	0.58		0.66	0.9	-0.27	0.47	0.48	0.82	-0.07	0.88	0.02	0.13	0.77	0.85	0.87	0.75	0.76	0.1	0.92	0.94
Cash	0.66	0.43	-0.22	0.53	0.68	0.63	0.24	0.66		0.63	-0.15	0.75	0.13	0.44	0.08	0.66	-0.12	0.07	0.59	0.67	0.49	0.75	0.4	0.42	0.63	0.61
Non Current Assets Total	0.98	0.48	-0.38	0.81	0.97	0.99	0.76	0.9	0.63		-0.19	0.42	0.39	0.83	0.01	0.8	0.07	0.1	0.9	0.93	0.89	0.81	0.89	0.14	0.94	0.96
Non Currrent Assets Other	-0.25	0.39	-0.53	-0.46	-0.15	-0.12	-0.31	-0.27	-0.15	-0.19		-0.18	0.24	-0.3	-0.01	-0.48	-0.49	0.04	-0.32	-0.29	-0.26	-0.35	-0.4	0.35	-0.2	-0.21
Cash And Short Term Investments	0.5	0.31	-0.16	0.42	0.47	0.43	0.15	0.47	0.75	0.42	-0.18		0.17	0.24	0.23	0.5	-0.06	-0.06	0.49	0.56	0.27	0.67	0.17	0.19	0.4	0.41
Net Receivables	0.43	0.73	-0.24	0.32	0.51	0.47	0.08	0.48	0.13	0.39	0.24	0.17		0.43	-0.07	0.18	0.06	0.26	0.31	0.44	0.46	0.35	0.13	0.09	0.48	0.53
Common Stock Shares Outstanding	0.8	0.57	-0.15	0.74	0.86	0.85	0.53	0.82	0.44	0.83	-0.3	0.24	0.43		-0.35	0.68	0.37	0.5	0.68	0.75	0.97	0.58	0.76	0.19	0.92	0.9
Non Current Liabilities Total	0.09	-0.27	-0.18	0.0	-0.09	-0.04	0.37	-0.07	0.08	0.01	-0.01	0.23	-0.07	-0.35		0.12	-0.08	-0.73	0.25	0.16	-0.3	0.15	-0.1	-0.46	-0.17	-0.12
Inventory	0.83	0.25	-0.31	0.96	0.75	0.77	0.71	0.88	0.66	0.8	-0.48	0.5	0.18	0.68	0.12		0.04	-0.03	0.84	0.84	0.72	0.8	0.76	0.01	0.78	0.79
Other Current Assets	0.1	0.03	0.33	0.12	0.08	0.07	0.1	0.02	-0.12	0.07	-0.49	-0.06	0.06	0.37	-0.08	0.04		0.32	0.11	0.12	0.24	-0.02	0.07	-0.25	0.14	0.14
Other Stockholder Equity	0.07	0.46	0.03	0.06	0.21	0.18	-0.26	0.13	0.07	0.1	0.04	-0.06	0.26	0.5	-0.73	-0.03	0.32		-0.07	0.04	0.43	-0.03	0.05	0.6	0.34	0.26
Total Liab	0.95	0.27	-0.41	0.85	0.81	0.87	0.88	0.77	0.59	0.9	-0.32	0.49	0.31	0.68	0.25	0.84	0.11	-0.07		0.97	0.72	0.91	0.84	0.02	0.8	0.82
Total Current Assets	0.98	0.44	-0.34	0.84	0.9	0.91	0.76	0.85	0.67	0.93	-0.29	0.56	0.44	0.75	0.16	0.84	0.12	0.04	0.97		0.78	0.92	0.81	0.06	0.88	0.9
Common Stock	0.85	0.53	-0.23	0.78	0.89	0.91	0.58	0.87	0.49	0.89	-0.26	0.27	0.46	0.97	-0.3	0.72	0.24	0.43	0.72	0.78		0.64	0.81	0.22	0.93	0.93
Accounts Payable	0.88	0.32	-0.3	0.81	0.77	0.78	0.64	0.75	0.75	0.81	-0.35	0.67	0.35	0.58	0.15	0.8	-0.02	-0.03	0.91	0.92	0.64		0.7	0.22	0.74	0.76
Short Term Debt	0.86	0.14	-0.21	0.78	0.8	0.85	0.84	0.76	0.4	0.89	-0.4	0.17	0.13	0.76	-0.1	0.76	0.07	0.05	0.84	0.81	0.81	0.7		-0.02	0.8	0.83
Short Term Investments	0.1	0.43	-0.32	0.05	0.17	0.18	-0.24	0.1	0.42	0.14	0.35	0.19	0.09	0.19	-0.46	0.01	-0.25	0.6	0.02	0.06	0.22	0.22	-0.02		0.23	0.16
Other Liab	0.93	0.65	-0.3	0.79	0.97	0.96	0.6	0.92	0.63	0.94	-0.2	0.4	0.48	0.92	-0.17	0.78	0.14	0.34	0.8	0.88	0.93	0.74	0.8	0.23		0.99
Net Tangible Assets	0.95	0.61	-0.29	0.81	0.99	0.98	0.64	0.94	0.61	0.96	-0.21	0.41	0.53	0.9	-0.12	0.79	0.14	0.26	0.82	0.9	0.93	0.76	0.83	0.16	0.99

Click cells to compare fundamentals

Mangalam Drugs Account Relationship Matchups

Mangalam Drugs fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.6B	3.3B	3.6B	3.3B	3.8B	2.1B
Short Long Term Debt Total	4.8B	4.2B	3.6B	1.1B	1.2B	2.2B
Other Current Liab	17.6M	13.9M	35.2M	94.0M	84.6M	72.1M
Total Current Liabilities	1.1B	1.3B	1.7B	1.6B	1.9B	2.0B
Total Stockholder Equity	1.3B	1.5B	1.5B	1.4B	1.6B	841.8M
Property Plant And Equipment Net	1.2B	1.3B	1.3B	1.3B	1.5B	884.7M
Net Debt	691.1M	859.6M	796.1M	1.1B	1.2B	682.2M
Retained Earnings	825.1M	1.0B	1.0B	867.3M	997.4M	1.0B
Cash	5.9M	19.5M	26.8M	11.9M	13.7M	10.3M
Non Current Assets Total	1.3B	1.5B	1.5B	1.6B	1.8B	950.0M
Non Currrent Assets Other	26.9M	24.1M	8.8M	928K	1.1M	1.0M
Cash And Short Term Investments	5.9M	19.5M	99.9M	11.9M	13.7M	16.9M
Net Receivables	710.3M	616.7M	465.8M	279.4M	321.4M	426.9M
Liabilities And Stockholders Equity	2.6B	3.3B	3.6B	3.3B	3.8B	2.1B
Non Current Liabilities Total	242.5M	477.5M	423.2M	338.5M	304.6M	273.1M
Inventory	585.9M	1.2B	1.4B	1.2B	1.4B	1.5B
Other Current Assets	17.6M	17.4M	125.5M	232.3M	267.1M	147.7M
Other Stockholder Equity	1.0B	223.8M	228.0M	332.3M	382.2M	446.0M
Total Liab	1.3B	1.8B	2.1B	2.0B	2.3B	1.2B
Total Current Assets	1.3B	1.8B	2.1B	1.8B	2.0B	1.1B
Accumulated Other Comprehensive Income	102.5M	103.6M	107.9M	2K	2.3K	2.4K
Accounts Payable	426.8M	545.5M	970.7M	661.6M	760.9M	426.8M
Short Term Debt	596.4M	575.9M	567.8M	885.0M	1.0B	525.3M
Other Liab	122.9M	141.8M	174.3M	168.1M	193.3M	117.7M
Net Tangible Assets	978.0M	1.2B	1.4B	1.3B	1.5B	973.9M
Other Assets	1K	63.0M	(1K)	434.7M	1.2K	1.1K
Long Term Debt	68.8M	3.6B	187.7M	133.5M	120.2M	114.2M
Short Long Term Debt	511.8M	471.0M	495.7M	746.0M	857.9M	509.9M
Property Plant Equipment	961.7M	1.2B	1.3B	11.8B	13.5B	14.2B
Long Term Debt Total	3.5B	4.2B	3.7B	3.0B	3.4B	3.3B
Intangible Assets	84.7M	138.8M	183.0M	285.2M	328.0M	344.4M
Current Deferred Revenue	35.7M	165.9M	79.8M	46.6M	53.6M	63.7M
Net Invested Capital	1.9B	2.2B	2.2B	2.2B	2.6B	2.1B
Net Working Capital	243.4M	473.6M	412.3M	119.4M	137.3M	273.2M
Capital Lease Obligations	57.4M	90.9M	139.5M	105.4M	121.2M	90.8M
Property Plant And Equipment Gross	2.0B	2.1B	1.3B	1.3B	1.2B	1.3B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Other Information on Investing in Mangalam Stock

Balance Sheet is a snapshot of the financial position of Mangalam Drugs And at a specified time, usually calculated after every quarter, six months, or one year. Mangalam Drugs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Mangalam Drugs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Mangalam currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mangalam Total Liab vs Non Currrent Assets Other Analysis

Total Liab vs Non Currrent Assets Other

Total Liab vs Non Currrent Assets Other Correlation Analysis

Correlation Coefficient

Total Liab

Non Currrent Assets Other

Mangalam Drugs fundamental ratios Correlations

Mangalam Drugs Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Mangalam Drugs fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Mangalam Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 0.99	Total Stockholder Equity
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Net Tangible Assets	+ 0.99	Other Liab
Non Current Assets Total	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Total Assets
Property Plant And Equipment Net	+ 0.98	Total Stockholder Equity

Other Stockholder Equity	- 0.73	Non Current Liabilities Total
Non Currrent Assets Other	- 0.53	Other Current Liab
Other Current Assets	- 0.49	Non Currrent Assets Other
Inventory	- 0.48	Non Currrent Assets Other
Short Term Investments	- 0.46	Non Current Liabilities Total
Non Currrent Assets Other	- 0.46	Total Current Liabilities